• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA修饰相关基因揭示食管鳞状细胞癌的预后特征及机制

RNA modification-related genes illuminate prognostic signature and mechanism in esophageal squamous cell carcinoma.

作者信息

Han Hui, Sun Yucong, Wei Wei, Huang Zixin, Cheng Maosheng, Qiu Hongshen, Wang Juan, Zheng Siyi, Liu Lianlian, Zhang Qiang, Zhang Canfeng, Ma Jieyi, Guo Siyao, Wang Zhaoyu, Li Zhenpeng, Jiang Xu, Lin Shuibin, Liu Qianwen, Zhang Shuishen

机构信息

Center for Translational Medicine, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.

Key Laboratory of Systems Biomedicine (Ministry of Education), Shanghai Center for Systems Biomedicine, Shanghai Jiao Tong University, Shanghai 200240, China.

出版信息

iScience. 2024 Feb 24;27(3):109327. doi: 10.1016/j.isci.2024.109327. eCollection 2024 Mar 15.

DOI:10.1016/j.isci.2024.109327
PMID:38487015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10937836/
Abstract

Emerging studies have demonstrated the link between RNA modifications and various cancers, while the predictive value and functional mechanisms of RNA modification-related genes (RMGs) in esophageal squamous cell carcinoma (ESCC) remain unclear. Here we established a prognostic signature for ESCC based on five RMGs. The analysis of ESCC clinical samples further verified the prognostic power of the prognostic signature. Moreover, we found that the knockdown of NSUN6 promotes ESCC progression and , whereas the overexpression of NSUN6 inhibits the malignant phenotype of ESCC cells. Mechanically, NSUN6 mediated tRNA mC modifications selectively enhance the translation efficiency of mRNA in a codon dependent manner. Rescue assays revealed that E-cadherin is an essential downstream target that mediates NSUN6's function in the regulation of ESCC progression. These findings offer additional insights into the link between ESCC and RMGs, as well as provide potential strategies for ESCC management and therapy.

摘要

新兴研究已证明RNA修饰与多种癌症之间的联系,而RNA修饰相关基因(RMGs)在食管鳞状细胞癌(ESCC)中的预测价值和功能机制仍不清楚。在此,我们基于五个RMGs建立了ESCC的预后特征。对ESCC临床样本的分析进一步验证了该预后特征的预后能力。此外,我们发现敲低NSUN6会促进ESCC进展,而NSUN6的过表达则会抑制ESCC细胞的恶性表型。从机制上讲,NSUN6介导的tRNA mC修饰以密码子依赖性方式选择性地提高mRNA的翻译效率。挽救实验表明,E-钙黏蛋白是介导NSUN6在ESCC进展调控中功能的重要下游靶点。这些发现为ESCC与RMGs之间的联系提供了更多见解,并为ESCC的管理和治疗提供了潜在策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/3bb240f8b016/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/7f5611473e38/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/db5709a10658/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/6cd2153cffa6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/dd84aa61a2d1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/eac338ce8533/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/87f8cd764b59/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/66d9df0125be/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/3bb240f8b016/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/7f5611473e38/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/db5709a10658/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/6cd2153cffa6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/dd84aa61a2d1/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/eac338ce8533/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/87f8cd764b59/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/66d9df0125be/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c934/10937836/3bb240f8b016/gr7.jpg

相似文献

1
RNA modification-related genes illuminate prognostic signature and mechanism in esophageal squamous cell carcinoma.RNA修饰相关基因揭示食管鳞状细胞癌的预后特征及机制
iScience. 2024 Feb 24;27(3):109327. doi: 10.1016/j.isci.2024.109327. eCollection 2024 Mar 15.
2
circCYP24A1 facilitates esophageal squamous cell carcinoma progression through binding PKM2 to regulate NF-κB-induced CCL5 secretion.环状 RNA CYP24A1 通过结合 PKM2 调节 NF-κB 诱导的 CCL5 分泌促进食管鳞癌进展。
Mol Cancer. 2022 Dec 13;21(1):217. doi: 10.1186/s12943-022-01686-7.
3
Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.食管鳞癌中 PD-L1 表达、免疫浸润与 m6A RNA 甲基化调控因子的综合分析
Front Immunol. 2021 May 12;12:669750. doi: 10.3389/fimmu.2021.669750. eCollection 2021.
4
A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis.一种来自LOXL2和肌动蛋白相关蛋白的蛋白质-蛋白质相互作用网络的三基因特征用于食管鳞状细胞癌预后评估。
Cancer Med. 2017 Jul;6(7):1707-1719. doi: 10.1002/cam4.1096. Epub 2017 May 29.
5
Identification of mC-related lncRNAs signature to predict prognosis and therapeutic responses in esophageal squamous cell carcinoma patients.鉴定 mC 相关 lncRNAs 特征,以预测食管鳞癌患者的预后和治疗反应。
Sci Rep. 2023 Sep 4;13(1):14499. doi: 10.1038/s41598-023-41495-6.
6
RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma.RNA m6A 去甲基酶 FTO 通过表观遗传调控 LINC00022 的上调促进食管鳞状细胞癌的发生。
J Exp Clin Cancer Res. 2021 Sep 20;40(1):294. doi: 10.1186/s13046-021-02096-1.
7
N-methylguanosine tRNA modification promotes esophageal squamous cell carcinoma tumorigenesis via the RPTOR/ULK1/autophagy axis.N-甲基鸟苷转移 RNA 修饰通过 RPTOR/ULK1/自噬轴促进食管鳞状细胞癌发生。
Nat Commun. 2022 Mar 18;13(1):1478. doi: 10.1038/s41467-022-29125-7.
8
A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.成纤维细胞相关特征可预测食管鳞癌的预后和免疫治疗反应。
Front Immunol. 2023 May 29;14:1199040. doi: 10.3389/fimmu.2023.1199040. eCollection 2023.
9
High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.高 MLL2 表达通过诱导 EMT 促进食管鳞癌的进展,预示着不良预后。
J Cancer Res Clin Oncol. 2018 Jun;144(6):1025-1035. doi: 10.1007/s00432-018-2625-5. Epub 2018 Mar 12.
10
N-methylguanosine (mG) tRNA modification: a novel autophagy modulator in cancer.N-甲基鸟苷(mG)tRNA 修饰:癌症中一种新的自噬调节剂。
Autophagy. 2023 Jan;19(1):360-362. doi: 10.1080/15548627.2022.2077551. Epub 2022 May 23.

引用本文的文献

1
Advances in radiotherapy in the treatment of esophageal cancer.食管癌放射治疗的进展
World J Clin Oncol. 2025 Mar 24;16(3):102872. doi: 10.5306/wjco.v16.i3.102872.
2
Targeting TSPEAR-AS2 suppresses tumor growth and interferon signaling in esophageal cancer.靶向 TSPEAR-AS2 抑制食管癌的肿瘤生长和干扰素信号通路。
Sci Rep. 2024 Nov 20;14(1):28768. doi: 10.1038/s41598-024-80439-6.
3
The role of m5C RNA modification in cancer development and therapy.m5C RNA修饰在癌症发生发展及治疗中的作用。

本文引用的文献

1
Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 checkpoint inhibition.可切除食管腺癌患者新辅助 PD-L1 检查点抑制治疗的纵向免疫监测。
Oncoimmunology. 2023 Jul 17;12(1):2233403. doi: 10.1080/2162402X.2023.2233403. eCollection 2023.
2
NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer.NAT10 介导的 ac4C tRNA 修饰促进癌症中 EGFR mRNA 的翻译和吉非替尼耐药性。
Cell Rep. 2023 Jul 25;42(7):112810. doi: 10.1016/j.celrep.2023.112810. Epub 2023 Jul 18.
3
Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer.
Heliyon. 2024 Sep 27;10(19):e38660. doi: 10.1016/j.heliyon.2024.e38660. eCollection 2024 Oct 15.
异常的 m5C 高甲基化通过 NSUN2/YBX1/QSOX1 轴介导 EGFR 突变型非小细胞肺癌对吉非替尼的内在耐药性。
Mol Cancer. 2023 May 9;22(1):81. doi: 10.1186/s12943-023-01780-4.
4
Comprehensive multi-omics analysis of the m7G in pan-cancer from the perspective of predictive, preventive, and personalized medicine.从预测、预防和个性化医学角度对泛癌中m7G进行全面多组学分析。
EPMA J. 2022 Nov 22;13(4):671-697. doi: 10.1007/s13167-022-00305-1. eCollection 2022 Dec.
5
Targeting tumour-intrinsic N-methylguanosine tRNA modification inhibits MDSC recruitment and improves anti-PD-1 efficacy.靶向肿瘤内在的N-甲基鸟苷tRNA修饰可抑制髓源性抑制细胞募集并提高抗程序性死亡蛋白1疗效。
Gut. 2023 Aug;72(8):1555-1567. doi: 10.1136/gutjnl-2022-327230. Epub 2022 Oct 25.
6
METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.METTL1 介导的 m7G tRNA 修饰促进肝癌对仑伐替尼的耐药性。
Cancer Res. 2023 Jan 4;83(1):89-102. doi: 10.1158/0008-5472.CAN-22-0963.
7
N-methyladenosine (mA) in 18S rRNA promotes fatty acid metabolism and oncogenic transformation.m6A 在 18S rRNA 中促进脂肪酸代谢和致癌转化。
Nat Metab. 2022 Aug;4(8):1041-1054. doi: 10.1038/s42255-022-00622-9. Epub 2022 Aug 23.
8
N-methylguanosine (mG) tRNA modification: a novel autophagy modulator in cancer.N-甲基鸟苷(mG)tRNA 修饰:癌症中一种新的自噬调节剂。
Autophagy. 2023 Jan;19(1):360-362. doi: 10.1080/15548627.2022.2077551. Epub 2022 May 23.
9
Developmental mRNA mC landscape and regulatory innovations of massive mC modification of maternal mRNAs in animals.动物中大量 mC 修饰的母体 mRNAs 的发育性 mRNA mC 图谱和调控创新。
Nat Commun. 2022 May 5;13(1):2484. doi: 10.1038/s41467-022-30210-0.
10
Cancer Diagnosis, Treatment Linked to Suicide Risk.癌症诊断与治疗与自杀风险相关。
Cancer Discov. 2022 Jun 2;12(6):OF2. doi: 10.1158/2159-8290.CD-NB2022-0032.